Lys(199) mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists

J Renin Angiotensin Aldosterone Syst. 2000 Sep;1(3):283-8. doi: 10.3317/jraas.2000.044.

Abstract

Many slow dissociating (insurmountable) non-peptide angiotensin type 1 receptor (AT1) antagonists contain,besides the acidic biphenyltetrazole substructure of losartan, a second acidic group to stabilise antagonist-receptor complexes. To investigate the involved basic amino-acids of the human AT1-receptor, wild-type and mutant receptors were transiently transfected in CHO-K1 cells and characterised by [3H]candesartan binding. Lys199-->Gln substitution decreased the affinity 45-fold for candesartan (95% insurmountable),18-fold for EXP3174 (70% insurmountable), 10-fold for irbesartan (40% insurmountable) and 5-fold for losartan (surmountable). His256 -->Ala substitution had only minor effects. This suggests that Lys199 is important for the tight binding of non-peptide antagonists.

MeSH terms

  • Amino Acid Sequence / genetics
  • Angiotensin Receptor Antagonists
  • Animals
  • Benzimidazoles / metabolism
  • Binding, Competitive
  • Biphenyl Compounds
  • CHO Cells
  • Cricetinae
  • Humans
  • Ligands
  • Mutation / physiology*
  • Receptor, Angiotensin, Type 1
  • Receptors, Angiotensin / genetics*
  • Receptors, Angiotensin / metabolism*
  • Tetrazoles / metabolism

Substances

  • Angiotensin Receptor Antagonists
  • Benzimidazoles
  • Biphenyl Compounds
  • Ligands
  • Receptor, Angiotensin, Type 1
  • Receptors, Angiotensin
  • Tetrazoles
  • candesartan